Comparison of Telavancin and Vancomycin for Hospital-acquired Pneumonia Due to Methicillin-resistant Staphylococcus Aureus

Clinical trial NCT00124020 · COMPLETED

Trial details

NCT number: NCT00124020
Sponsor: Cumberland Pharmaceuticals
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Bacterial Pneumonia

Start date: 2005-01-01
Primary completion: 2007-05-01
Enrollment: 771

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.